● Recruiting

MEthylphenidate in ADHD - Addiction(s) Comorbidity: Value of Adding a Cognitive Remediation Program to Improve Short- and Medium-term Therapeutic Response

Condition: ADHD-add · Sponsor: Nantes University Hospital

PhaseNA

Planned participants248

Who can joinAll sexes, 18 Years to 99 Years

Healthy volunteersNo

About this study

MEthylphenidate in ADHD - Addiction(s) comorbidity: benefit of adding a cognitive remediation program to improve short- and medium-term therapeutic response

This description comes directly from the study's public registry record.

Talk to the study team

Clémence Dr Cabelguen, MD-Phd · 33240846116 · clemence.cabelguen@chu-nantes.fr

Always discuss trial participation with your own doctor first.

Locations (6)

CHRU Brest	Brest, Brittany Region, France	Not Yet Recruiting
EPSM du Finistère Sud	Quimper, Brittany Region, France	Not Yet Recruiting
EPSM Georges Daumézon (Fleury-les-Aubrais, Loiret)	Fleury-les-Aubrais, Centre-Val de Loire, France	Not Yet Recruiting
CHRU de Tours	Tours, Centre-Val de Loire, France	Not Yet Recruiting
CH Georges Daumézon - Bouguenais	Bouguenais, Loire-Atlantique, France	Not Yet Recruiting
CHU Nantes	Nantes, France	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06906328